In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, examines the most common threats to trial data reliability, including opaque methodologies, synthetic controls, and the limits of ...

That's the purpose of the estimand framework—to define ahead of time, before you even start randomizing patients, everything that can happen, and then define the methods you will use to attenuate the ...

Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

His vision came to fruition in what is now an 80,000 square foot complex with an on-site animal research facility, dedicated regenerative medicine laboratory, expansive infusion area, in-house MRI ...

They live in our houses, drink our water and even sleep in our beds. Cats have become an integral part of many households and ...

Evidence suggests the widespread adoption of trauma-informed care practices can potentially improve access to care as well as ...

We are pleased to present additional data that further underscore the wide-ranging therapeutic potential of rinvatercept,” said Jasbir S. Seehra, President and Chief Executive Officer of Keros. “These ...

Polyrizon Ltd. (Nasdaq: PLRZ) ('Polyrizon” or the 'Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced the successful production of a ...

With pressure from global competitors and recent changes in domestic policy threatening to undermine U.S. leadership in this ...

"President Trump and RFK Jr. promised to 'Make America Healthy Again.' But instead, the administration has done quite the ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

The Mid Yorkshire Teaching NHS Trust has said that they are “proud” to be working in partnership with Conexus Healthcare, ...